Abstract
COVID-19 has been associated with hemolytic anemia in pediatric as well as adult age group. However, very little is known about the clinical course and immune responses in newborn born to a mother who contracted SARS-CoV-2 infection during pregnancy. Previously, few cases of autoimmune hemolytic anemia with SARS-CoV-2 infection due to the cytokine storm or through molecular mimicry has been found. Through this report, we would discuss about the SARS-COV-2 reactive antibodies as a potential etiology of severe early hemolysis leading to severe neonatal hyperbilirubinemia in a neonate born to a mother with SARS-CoV-2 infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
